Feeling queasy on the shot is the single most common thing people deal with, and it is not a sign you are doing anything wrong. GLP-1 medicines (semaglutide, sold as Ozempic and Wegovy; tirzepatide, sold as Mounjaro and Zepbound) slow how fast your stomach empties, so food sits longer and meals feel heavier, and they also act on the appetite and nausea centers in your brain. Nausea shows up most when you first start and after each dose increase, and for most people it is mild to moderate and eases over the first several weeks as your body settles in. Smaller, blander meals and a slow, prescriber-directed dose increase usually help. This is general information, not medical advice.
What causes GLP-1 nausea?
First, the reassuring part: nausea is the most common thing people report on these medicines, and most of the time it is your body adjusting, not a sign something is wrong. Here is what is going on. GLP-1 medicines work partly by slowing gastric emptying, which is just the medical way of saying they slow how quickly food leaves your stomach. Cleveland Clinic explains this is part of how the medicines lower blood sugar and curb appetite, and that fuller, heavier feeling is one reason a meal can bring on queasiness.
Slowed digestion is not the whole story, though. These medicines also act on the appetite and nausea centers in your brain, and Harvard Health describes the mechanism behind GLP-1 nausea as involving those central effects. The honest truth is the exact mechanism is not settled: researchers are still weighing how much comes from the stomach versus the brain. What is clear is that nausea is the most commonly reported effect of this whole class, right alongside other stomach effects like vomiting and diarrhea.
How common is this?
It is the most common side effect across these medicines, but the reported rates vary by drug, dose, and which group was studied. A few numbers from the trials help set expectations:
- Semaglutide 2.4 mg (in the STEP weight-management program): nausea was reported by roughly 44% of people versus about 16% on placebo, and vomiting by about 25% versus 6%.
- Tirzepatide (in the SURMOUNT-1 obesity trial): nausea was reported by roughly 25 to 33% across doses.
- Tirzepatide in the SURPASS diabetes trials: nausea was lower, in the range of roughly 12 to 24%.
One gentle word of caution before you compare those side by side: they come from different trials and different groups of people, not a head-to-head test. So it would be a mistake to read them and decide one medicine "causes less nausea" than another, because that has not been established. The fair takeaway is that nausea is common with all of them, and that even placebo groups report some too. You are in very normal company.
How long will this last?
If you are hoping for a date on the calendar, the honest answer is that the pattern is more reliable than any single number. Nausea tends to flare when you first start and again after each dose increase, with most reports landing shortly after a step-up. When an episode hits, it is often short-lived: studies describe a median of around 8 days per episode. For most people it is mild to moderate and passing, easing over the first several weeks. Harvard Health notes that GLP-1 side effects like nausea usually resolve within a few weeks.
There is no fixed timeline, though, and "a few weeks" varies from person to person. Some people settle quickly; others have a rougher stretch around each step-up, and that is okay too. Cleveland Clinic notes the common stomach effects are more likely when you start or increase the dose. If your nausea is not improving, is getting worse, or is making it hard to eat and drink, that is worth a message to your prescriber. For the bigger picture, see how long GLP-1 side effects last.
What you can do tonight
None of these will change your medication or are a reason to skip or alter a dose on your own. They are the gentle, prescriber-approved things most people try first:
- Eat smaller, blander, lower-fat meals. Large or rich meals sit longer and tend to feel worse. Smaller portions are kinder while your body adjusts. Our foods to eat and avoid guide has the full picture.
- Eat slowly and stop at the first sign of fullness. With digestion slowed, fullness arrives sooner than you are used to, and pushing past it tends to bring on the queasiness.
- Steer clear of greasy, fried, and very sweet foods for now. These reliably sit heavy and make nausea worse.
- Try a simple settler. Ginger, in tea or candied form, and plain crackers help some people take the edge off.
- Sip fluids in small amounts through the day rather than gulping a lot at once, and get a little fresh air. A short walk and an open window do more than they sound like they should.
- Talk to your prescriber before changing your dose. A slow, gradual step-up is the single biggest lever there is, and it belongs to them, not to a forum. If nausea is rough, they may hold you at your current dose longer, lengthen the time before your next step-up, or step down and re-advance later. The same goes for anti-nausea medication: whether one fits, and which one, is a clinical decision, not something to start on your own.
When to call someone
Nausea by itself is almost always an uncomfortable but passing sign that your body is adjusting. The reason to know the warning signs is so you can tell the difference quickly and stop worrying about the ordinary version.
Most of the time, though, nausea on the shot is just your digestion running in slow motion while you adjust. Unpleasant, yes. A reason to panic, almost never.
Questions people ask at 11pm
Why does a GLP-1 make me feel so sick? Partly because semaglutide and tirzepatide slow how fast your stomach empties, so food lingers and meals feel heavier, and partly because they act on the appetite and nausea centers in your brain. The exact balance between the two is still debated, but the feeling itself is very common and usually passing.
How long will the nausea last? Usually it eases over the first several weeks as your body adjusts, and individual episodes often run around 8 days. There is no fixed timeline, and it varies from person to person. It flares most when you start and after each dose increase, and a slow, prescriber-directed step-up helps.
Does tirzepatide cause less nausea than semaglutide? That has not been established. The reported rates come from separate trials in different groups, not a head-to-head comparison, so it is not fair to rank them. Nausea is common with both. Please do not change medicines or doses to chase relief; talk to your prescriber first.
How we reviewed this: this page was written from authoritative medical sources, including Cleveland Clinic's overview of GLP-1 agonists, Harvard Health on GLP-1 side effects, and peer-reviewed work on the mechanism of GLP-1 nausea and dietary management of GLP-1 gastrointestinal effects. The semaglutide 2.4 mg figures are from the STEP program trials. See our editorial and review policy and sourcing standards. Where the evidence is unsettled, like the precise nausea mechanism and cross-trial rates that are not head-to-head, we tell you that instead of overstating it.
Every medical claim above is cited to a primary source such as an FDA label, the NIH, or a named clinical trial. See how we review and our sourcing & fact-check standards.